Clarius Group, LLC
- SEC CIK
- 0001664214
- Latest filing
- Jan 14, 2026
The latest 13F from Clarius Group, LLC covers Q4 2025 (filed Jan 14, 2026): 384 long positions worth $1.75B. The top 10 holdings make up 59.6% of the portfolio, and the largest is Paccar Inc (PCAR) at 15.2%. Livermore has 20 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q4 2025
Share counts compared with Q3 2025: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 14
- Est. +$38.8M
- Added
- 99
- Est. +$16.1M
- Reduced
- 157
- Est. −$36.4M
- Sold out
- 28
- Est. −$8.51M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
- Capital Group Global Equity14020R107+$34.9MNew
- Vanguard BD Index FDS92203C303+$5.25MAdded
- iShares Core MSCI Emerging Markets ETF46434G103+$1.33MAdded
- Dimensional ETF Trust25434V765+$1.23MAdded
- iShares Tr46435G326+$988.4KAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Capital Group Global Equity14020R107+1.99 pp0.0% → 2.0%
- PCARPaccar Inc
- Vanguard BD Index FDS92203C303+0.27 pp0.9% → 1.2%
- Dimensional ETF Trust25434V765+0.09 pp4.8% → 4.9%
- iShares Core MSCI Emerging Markets ETF46434G103+0.07 pp0.3% → 0.4%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q4 2025, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $1.75B
- +$62.2M (+3.7%) vs. prior quarter
- Positions
- 384
- −14 vs. prior quarter
- Top 10 concentration
- 59.6%
- Top 10 as share of value
- Turnover
- 2.6%
- Q4 2025, one quarter
- Average holding period
- 17.9 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
20 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $1.75B (Q4 2025)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Jan 14, 2026 | 384 | $1.75B | PCARMSFTVanguard S&P 500 ETF | vs. Q3 2025 | SEC |
| Q3 2025 | Oct 14, 2025 | 398 | $1.69B | PCARMSFTVanguard S&P 500 ETF | vs. Q2 2025 | SEC |
| Q2 2025 | Jul 22, 2025 | 480 | $1.72B | PCARMSFTVanguard S&P 500 ETF | vs. Q1 2025 | SEC |
| Q1 2025 | Apr 18, 2025 | 482 | $1.59B | PCARMSFTVanguard S&P 500 ETF | vs. Q4 2024 | SEC |
| Q4 2024 | Jan 16, 2025 | 452 | $1.46B | PCARMSFTVanguard S&P 500 ETF | vs. Q3 2024 | SEC |
| Q3 2024 | Oct 9, 2024 | 453 | $1.43B | PCARMSFTVanguard S&P 500 ETF | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 11, 2024 | 447 | $1.41B | PCARMSFTVanguard S&P 500 ETF | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 17, 2024 | 484 | $1.45B | PCARMSFTVanguard S&P 500 ETF | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 29, 2024 | 477 | $1.21B | MSFTPCARSchwab Fundamental U.S. Small Company ETF | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 19, 2023 | 461 | $1.05B | MSFTPCARSchwab Fundamental U.S. Small Company ETF | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 10, 2023 | 490 | $1.29B | PCARMSFTAMZN | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 17, 2023 | 510 | $1.18B | PCARMSFTInvesco Exch TRD SLF Idx FD | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 25, 2023 | 515 | $1.11B | PCARMSFTSchwab Fundamental U.S. Small Company ETF | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 24, 2022 | 494 | $1.00B | PCARMSFTAMZN | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 10, 2022 | 470 | $1.00B | PCARMSFTAMZN | vs. Q1 2022 | SEC |
| Q1 2022 | Apr 8, 2022 | 493 | $1.26B | MSFTPCARAMZN | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 2, 2022 | 493 | $1.26B | MSFTPCARAMZN | vs. Q3 2021 | SEC |
| Q3 2021 | Oct 18, 2021 | 432 | $1.12B | PCARMSFTAMZN | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 6, 2021 | 422 | $1.11B | PCARMSFTAMZN | vs. Q1 2021 | SEC |
| Q1 2021 | Apr 27, 2021 | 386 | $1.00B | PCARMSFTAMZN | – | SEC |